INSILICO (03696.HK): to be included in MSCI Global Small Cap Index, effective after market close on 31 August

NewTimeSpace News: On 17 August 2026, InSilico Medicine (stock code: 03696) announced in a voluntary announcement that it will be included in the MSCI Global Small Cap Index, which aims to reflect the performance of small-cap companies across developed and emerging markets, effective after the market close on Monday, 31 August 2026.

According to the announcement, since its listing, the Company has been included in several major index series prior to this inclusion, including the CSI index series (CSI HK Connect Innovative Pharma Index, CSI Hong Kong Innovative Pharma Index and CSI HK Connect Healthcare Composite Index), the Hang Seng Composite Index, the Hang Seng Healthcare Index, the Hang Seng Biotechnology Index, as well as the FTSE Global Small Cap Index, the FTSE Global All-Cap Index and the FTSE Global Total Cap Index.

The Board considers that the inclusion in the MSCI Global Small Cap Index reflects the capital market's growing recognition of the Company's core competitive advantages, scalable business model and commercial potential. The inclusion is expected to raise the Company's profile among international institutional investors and research analysts, attract passive fund inflows tracking the relevant indices, diversify its shareholder base and improve the trading liquidity of its shares.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.